Hyperprogressive Disease (Hpd) Is Frequent In Non-Small Cell Lung Cancer (Nsclc) Patients (Pts) Treated With Anti Pd1/Pd-L1 Monoclonal Antibodies (Io)R. Ferrara, C. Caramella, M. Texier,C. Audigier Valette, L. Tessonnier,L. Mezquita,J. Lahmar,J. Mazieres,G. Zalcman,S. Brosseau,V. Westeel,S. Le Moulec,L. Leroy,B. Duchemann, R. Veillon,D. Planchard,M-E. Boucher,S. Koscielny,J-C. Soria,B. BesseANNALS OF ONCOLOGY（2017）引用 20|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
